Emerging Infectious Diseases
Overview
Emerging Infectious Diseases is a peer-reviewed scientific journal that focuses on the latest research and developments in the field of infectious diseases. It covers a wide range of topics, including emerging pathogens, outbreaks, epidemiology, diagnostics, prevention, and control strategies. With a global perspective, this journal provides valuable insights into the ever-evolving landscape of infectious diseases and their impact on public health.
Details
Details
Abbr.
Emerg Infect Dis
Start
1995
End
Continuing
Frequency
Bimonthly, 1999-
p-ISSN
1080-6040
e-ISSN
1080-6059
Country
United States
Language
English
Specialty
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 306
264
SJR / Ranks: 1096
2117
CiteScore / Ranks: 573
15.60
JIF / Ranks: 338
11.8
Recent Articles
1.
Jiang J, Long T, Porter A, Lovey A, Lee A, Jacob J, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40072602
Carbapenem-resistant and virulence plasmid-harboring Klebsiella pneumoniae (pVir-CRKP) has emerged and spread globally, yet clinical investigations from the United States remain limited. We conducted a genomic analysis of 884 unique carbapenem-resistant...
2.
Kaiser F, Cardenas S, Yinda K, Mukesh R, Ochwoto M, Gallogly S, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40072542
We measured stability of infectious influenza A(H5N1) virus in irradiated raw milk and wastewater and on surfaces. We found a relatively slow decay in milk, indicating that contaminated milk and...
3.
de Lima S, Hua X, Claro I, Filho C, Simoes Mello L, de Jesus R, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40072503
During May-December 2024, we detected Oropouche virus (OROV) in 13.9% (263/1,890) of febrile patients in Ceará state, Brazil. Genomic sequencing revealed those cases were caused by a novel OROV reassortant...
4.
Cruz C, Espejo V, Espinoza A, Castillo-Ore R, Troncos G, Ampuero J, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40064474
We describe introduction of the 2022-2023 Oropouche virus lineage from Brazil, which has caused large-scale outbreaks throughout Brazil, into the Amazon Region of Peru. This lineage is co-circulating with another...
5.
Pascua P, Chesnokov A, Nguyen H, Di H, La Cruz J, Jang Y, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40064473
During 2023-2024, highly pathogenic avian influenza A(H5N1) viruses from clade 2.3.2.1c caused human infections in Cambodia and from clade 2.3.4.4b caused human infections in the Americas. We assessed the susceptibility...
6.
Levine M, Liu F, Bagdasarian N, Holiday C, Jefferson S, Li Z, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40053378
Since March 2024, highly pathogenic avian influenza A(H5N1) viruses have caused outbreaks in dairy cattle and poultry in the United States, and they continue to spill over into humans. However,...
7.
Paul R, Lorenzo F, Lopez B, Alegre M, Couvin D, Rastogi N, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):601-606.
PMID: 40023848
To reconstruct transmission chains of the multidrug-resistant tuberculosis Ch strain, which harbors a unique combination of resistance mutations, we analyzed genomes of 25 isolates from 12 patients with diagnosis during...
8.
Bi K, Bandekar S, Bouchnita A, Fox S, Meyers L
Emerg Infect Dis
. 2025 Mar;
31(3):636-638.
PMID: 40023827
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on...
9.
Klinkenberg E, de Haas P, Manyonge C, Namutebi J, Mujangi B, Mutunzi H, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):1-9.
PMID: 40023826
In 2020, fecal (stool) testing was recommended for diagnosing Mycobacterium tuberculosis complex (MTBC) infection in children by using the Cepheid Xpert MTB/RIF assay; since then, countries have begun implementing stool-based...
10.
Gerussi V, Petersen T, Bonnet I, Aubry A, Bachir M, Gyde E, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):633-636.
PMID: 40023825
High-dose isoniazid is recommended to treat multidrug-resistant tuberculosis (MDR TB). Among 958 MDR TB isolates identified in France during 2008-2022, 93.1% exhibited high-level isoniazid resistance, and molecular testing showed limited...